A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
Condition(s) studied
Investigational drug(s) / intervention(s)
Brepocitinib PO QD: Brepocitinib PO QD
Placebo PO QD: Placebo PO QD
Study summary
The purpose of this study is to determine the safety and efficacy of brepocitinib in participants with active, non-anterior (intermediate, posterior, or pan) non-infectious uveitis (NIU).
Eligibility
Primary outcome measure(s)
- Time to treatment failure on or after Period 1 Week 6 up to Period 1 Week 48 — 48 weeks
Trial sites (107)
| Facility | City | Region | Status |
|---|---|---|---|
| Clinical Trial Site | Phoenix | Arizona | |
| Clinical Trial Site | Phoenix | Arizona | |
| Clinical Trial Site | Bakersfield | California | |
| Clinical Trial Site | Beverly Hills | California | |
| Clinical Trial Site | Fullerton | California | |
| Clinical Trial Site | Irvine | California | |
| Clinical Trial Site | La Jolla | California | |
| Clinical Trial Site | Los Angeles | California | |
| Clinical Trial Site | Los Angeles | California | |
| Clinical Trial Site | Modesto | California | |
| Clinical Trial Site | Sacramento | California | |
| Clinical Trial Site | Aurora | Colorado | |
| Clinical Trial Site | Denver | Colorado | |
| Clinical Trial Site | Fort Lauderdale | Florida | |
| Clinical Trial Site | St. Petersburg | Florida | |
| Clinical Trial Site | Chicago | Illinois | |
| Clinical Trial Site | Oak Park | Illinois | |
| Clinical Trial Site | Carmel | Indiana | |
| Clinical Trial Site | Prairie Village | Kansas | |
| Clinical Trial Site | Baltimore | Maryland | |
| Clinical Trial Site | Boston | Massachusetts | |
| Clinical Trial Site | Waltham | Massachusetts | |
| Clinical Trial Site | Ann Arbor | Michigan | |
| Clinical Trial Site | Detroit | Michigan | |
| Clinical Trial Site | Detroit | Michigan | |
| Clinical Trial Site | Minneapolis | Minnesota | |
| Clinical Trial Site | Rochester | Minnesota | |
| Clinical Trial Site | St Louis | Missouri | |
| Clinical Trial Site | Omaha | Nebraska | |
| Clinical Trial Site | Palisades Park | New Jersey | |
| NYU Langone Health | New York | New York | |
| Clinical Trial Site | Rochester | New York | |
| Clinical Trial Site | Durham | North Carolina | |
| Clinical Trial Site | Winston-Salem | North Carolina | |
| Clinical Trial Site | Cleveland | Ohio | |
| Clinical Trial Site | Cleveland | Ohio | |
| Clinical Trial Site | Columbus | Ohio | |
| Clinical Trial Site | Portland | Oregon | |
| Clinical Trial Site | Portland | Oregon | |
| Clinical Trial Site | Erie | Pennsylvania |
+ 67 more sites — see the full list on the official registry below.
More Priovant Therapeutics, Inc. trials in the UK
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06431373 on ClinicalTrials.gov ↗ ← All trials in the UK